Tools

Cancer Center

Experimental Therapeutics

Overview

Working Together to Conquer Cancer

Tufts Medical Center in Boston has been providing world-class care for cancer patients since the 1940s. During that time, cancer treatment and research have become increasingly complex.

We founded the Experimental Therapeutics Program at Tufts MC to accelerate the discovery and delivery of new cancer therapies. Our program consolidates cancer research at Tufts MC so that our experts can easily share information and ideas with one another. In addition, our six state-of-the-art laboratory facilities provide access to the technology our researchers need to develop groundbreaking new treatments.

We focus our research efforts on:

  • Offering treatments to patients with tumors that have not responded to standard drugs
  • Developing new drugs to treat cancer more effectively and with fewer complications
  • Understanding the biology of cancer and how drug treatments work
  • Validating biomarkers for better diagnosis and more accurate prognosis

How Can I Benefit from Tufts MC Cancer Research?

If you've recently been diagnosed with cancer, you want to know you're getting the most effective care right from the start. Or, you may have already tried standard cancer treatments and are now looking for new options. Either way, our program can efficiently connect you with the care you need.

In the Experimental Therapeutics Program, physician researchers work side-by-side with laboratory scientists. This enables us to quickly take discoveries "from bench to bedside." As a patient, you'll feel confident that our team is offering you access to the latest therapies and the most promising clinical trials.

Meet the Experimental Therapeutics Team

Wasif Saif, MD, co-founded the Experimental Therapeutics Program in 2012. He is board-certified in medical oncology and ranked among the top 1% of oncologists nationwide by U.S. News & World Report. As a researcher, he has authored or co-authored over 350 publications and designed numerous Phase I and II clinical trials. Dr. Saif is also a professor at Tufts University School of Medicine, where he helps educate the next generation of medical leaders.

Our physicians and researchers come from many Tufts MC departments, including the Cancer Center, neurologyneurosurgery and radiology.

Participating departments at Tufts University include the:

  • School of Medicine
  • Sackler School of Graduate Biomedical Sciences
  • Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy
  • School of Dental Medicine
  • School of Arts and Sciences
  • School of Engineering
  • Jean Mayer USDA Human Nutrition Research Center on Aging
  • Cummings School of Veterinary Medicine

Doctors + Care Team

John K. Erban, MD

John K. Erban, MD

Title(s): Clinical Director, Tufts Cancer Center; Professor, Tufts University School of Medicine
Department(s): Medicine, Hematology/Oncology
Appt. Phone: 617-636-5757
Fax #: 617-636-7060

Breast cancer, clinical trials

More Info

Paul Mathew, MD

Paul Mathew, MD

Title(s): Genitourinary Oncologist; Associate Professor, Tufts University School of Medicine
Department(s): Medicine, Hematology/Oncology
Appt. Phone: 617-636-6227
Fax #: 617-636-8538

Clinical care of genitourinary cancers with a special emphasis on prostate cancer, modeling bone metastases and experimental therapeutics in prostate cancer and other genitourinary malignancies

More Info

Wasif M. Saif, MD

Wasif M. Saif, MD

Title(s): Director, GI Oncology Program; Leader, Experimental Therapeutics; Professor, Tufts University School of Medicine
Department(s): Medicine, Hematology/Oncology
Appt. Phone: 617-636-6227
Fax #: 617-636-8538

Chemistry and pharmacology of folate antagonist, experimental therapeutics, clinical trial design (Phase I and II), cancers treated include pancreas, gall bladder, cholangiocarcinoma (bile duct), anal, colon (including Rectum), neuroendocrine (carcinoid), psedomyxoma peritonei, esophagus, gastroesophageal (including Stomach), liver, unknown primary, GIST, adrenal, peritoneum, phase I clinical studies of novel cancer drugs and/or combinations

More Info

Referring Physician Resources

In the Experimental Therapeutics Program, we value our relationships with referring physicians, and we're committed to working with you to bring novel therapies to your cancer patients.


Call Us: 617-636-6227